Facial rejuvenation is a combination of cosmetic procedures that are used to restore the youthful appearance to the human face. Facial rejuvenation can be achieved through either surgical and/or non-surgical methods. The global market for facial rejuvenation has been segmented based on product type, end users, and five global regions.
Growth in the facial rejuvenation market is mainly driven by healthy economic growth witnessed in most countries, leading to rising in disposable income levels and lifestyle changes. These often lead to early onset of ageing, thus increasing demand for less painful rejuvenation treatment procedures and quicker results to remain youthful. However, lack of properly trained professionals and limited documented evidence of clinical effectiveness, are factors expected to restrain the growth of the market.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1593
International regulatory harmonization, spanning regions, is set to define the basis for establishing product efficacies, reducing complexity.
In terms of value, the global facial rejuvenation market is estimated to expand from a value of US$ 18 Bn in 2014 to a value of US$ 26.5 Bn by 2021 end at a CAGR of 4.9% during the forecast period.
Based on product type, the market has been segmented into topical products, botulinum, dermal fillers, chemical peels, microabrasion equipment and laser surfacing treatments. In terms of value, the botulinum product type is estimated to account for ~37% share of the global market by 2021 end, remaining dominant and the most attractive segment.
Inquiry on this report @ http://www.mrrse.com/enquiry/1593
On the basis of distribution channels, the market has been segmented into hospitals and dermatology clinics. The latter category is the most preferred medium of drug distribution and treatment advising.
The global facial rejuvenation market has been segmented into five major regions, namely North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. In terms of value, North America is estimated to dominate the market, accounting for over a third of the overall market by 2015 end. Latin America and Asia Pacific are estimated to be the fastest-growing emerging markets. Currently, botulinum products are a major revenue contributor in most regions. Among dermal fillers, the hyaluronic acid based fillers used for volume restoration are more preferred over other types. Growing popularity of combination treatments and their rising adoption among customers is expected to boost revenue growth of the facial rejuvenation market in the coming years.
Read Complete Report with TOC @ http://www.mrrse.com/facial-rejuvenation-market
Some of the key players identified in the global facial rejuvenation drug market report include Merz GmbH & Co. KGaA, LUMENIS, Revance Therapeutics, Inc., Biopolymer GmbH &Co KG, Speciality European Pharma, Mentor Worldwide LLC, Anika Therapeutics, Inc., Contura International A/S, Cynosure, Inc., Fibrocell, Inc., and Gal derma S/A. The report is enriched through identification of company-specific strategies related to drug development, market consolidation initiatives, and analyses of the various market player’s specific strengths, weaknesses, opportunities, and threats.
90 State Street,
Albany NY – 12207